Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors
- PMID: 1683709
- DOI: 10.1159/000138821
Evidence for heterogeneity of prejunctional alpha-2-adrenoceptors
Abstract
The interactions between SK&F 104078 and several selective alpha 2-adrenoceptor agonists at pre- and postjunctional alpha 2-adrenoceptors were investigated in order to assess the previously reported selectivity of SK&F 104078 for postjunctional alpha 2-adrenoceptors and to determine whether or not SK&F 104078 could uncover subtypes of alpha 2-adrenoceptors located prejunctionally as has also been suggested. The alpha 2-adrenoceptor agonists, UK 14,304, xylazine, B-HT 933, B-HT 920, clonidine and M-7, produced concentration-dependent prejunctional alpha 2-adrenoceptor-mediated inhibition of neurogenic responses in the guinea pig atrium and rat vas deferens and produced postjunctional alpha 2-adrenoceptor-mediated contraction of the canine saphenous vein. The alpha 2-adrenoceptor antagonist, rauwolscine, blocked all the agonists at both pre- and postjunctional alpha 2-adrenoceptors without demonstrating preference for any agonist or any synaptic location of alpha 2-adrenoceptors. In marked contrast, SK&F 104078 produced equivalent antagonism of all agonists in the canine saphenous vein but had no significant effect against the same agonists in the guinea pig atrium, suggesting a high degree of selectivity for postjunctional alpha 2-adrenoceptors in these test systems, consistent with our previous observations. In the rat vas deferens, however, SK&F 104078 significantly antagonized the prejunctional alpha 2-adrenoceptor-mediated effects of clonidine and M-7 but did not block the responses to UK 14,304, xylazine, B-HT 933 and B-HT 920. These results indicate that the prejunctional alpha 2-adrenoceptor antagonist effects of SK&F 104078 are tissue and agonist dependent, and that there may be at least two subtypes of prejunctional alpha 2-adrenoceptors that can be discriminated with SK&F 104078 but not with rauwolscine. Both subtypes of prejunctional alpha 2-adrenoceptors may be present in the rat vas deferens, while only the SK&F-104078-insensitive subtype is present in the guinea pig atrium.
Similar articles
-
Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856.J Pharmacol Exp Ther. 1991 Nov;259(2):643-52. J Pharmacol Exp Ther. 1991. PMID: 1682482
-
Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.Br J Pharmacol. 1991 Apr;102(4):943-9. doi: 10.1111/j.1476-5381.1991.tb12281.x. Br J Pharmacol. 1991. PMID: 1677300 Free PMC article.
-
Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors.J Pharmacol Exp Ther. 1988 Nov;247(2):645-52. J Pharmacol Exp Ther. 1988. PMID: 2903236
-
Evidence for and against heterogeneity of alpha 1-adrenoceptors.Life Sci. 1986 Apr 14;38(15):1339-50. doi: 10.1016/0024-3205(86)90466-2. Life Sci. 1986. PMID: 2870409 Review.
-
Ageing and alpha-adrenoceptors.Clin Sci (Lond). 1985;68 Suppl 10:133s-136s. doi: 10.1042/cs068s133. Clin Sci (Lond). 1985. PMID: 2857609 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources